Metraipolis › archive › dc_1fb11fdfcd42

Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms — Europe PMC PMID:41415561

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41415561
DOI
10.3389/fphar.2025.1702234
License (as archived)
solo-consultazione
Archived
2026-11-07T23:24:22.512Z
SHA-256 of the archived text
b3786a2408a118ea5738e60a2706e932c701e231484da55ddd72542817b23d26
Stable URL of this page
https://metraipolis.com/documento/dc_1fb11fdfcd42

How to cite

Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms — Europe PMC PMID:41415561 — Europe PMC (en), https://europepmc.org/article/MED/41415561 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fb11fdfcd42 (Metraipolis archive dc_1fb11fdfcd42, sha256 b3786a2408a118ea5738e60a2706e932c701e231484da55ddd72542817b23d26)
BibTeX
@misc{dc1fb11fdfcd42,
  title = {Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms — Europe PMC PMID:41415561},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41415561},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fb11fdfcd42; sha256 b3786a2408a118ea5738e60a2706e932c701e231484da55ddd72542817b23d26},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41415561. Agents can read the archived copy with the MCP tool read_document.